Cited by 1,089Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancerGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Trinucleotide repeat length instability and age of onset in Huntington's disease

Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., MacDonald, M.·1993·Nature Genetics

DOI 10.1038/ng0893-387

Open this paper in CoChat — free account

Abstract

The initial observation of an expanded and unstable trinucleotide repeat in the Huntington's disease gene has now been confirmed and extended in 150 independent Huntington's disease families. HD chromosomes contained 37-86 repeat units, whereas normal chromosomes displayed 11-34 repeats. The HD repeat length was inversely correlated with the age of onset of the disorder. The HD repeat was unstable in more than 80% of meiotic transmissions showing both increases and decreases in size with the largest increases occurring in paternal transmissions. The targeting of spermatogenesis as a particular source of repeat instability is reflected in the repeat distribution of HD sperm DNA. The analysis of the length and instability of individual repeats in members of these families has profound implications for presymptomatic diagnosis.

Integrity signals

Registry

Crossref · 10.1038/ng0893-387

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citation
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Self-citation
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Self-citation
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene
Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656
Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1
Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

SAS/STAT User's Guide, Version 6, 4th edn, Vol.2 (SAS Institute Inc., Cary, North Carolina, 1989).

Sorted by citations

Items 301–400 of 998

Familial Aggregation of Psychotic Symptoms in Huntington’s Disease
Tsuang, D. W., Almqvist, E. W., Lipe, H., Strgar, F., DiGiacomo, L., Hoff, D., Eugenio, C. J., Hayden, M. R., & Bird, T. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1955 · Cited by 67
Cortical myoclonus in huntington's disease
Thompson, P. D., Bhatia, K. P., Brown, P., Davis, M. B., Pires, M. M., Quinn, N. P., Luthert, P. J., Honovar, M., O’Brien, M. D., MARSDEN, C. D., et al. (1994) · Movement Disorders · doi:10.1002/mds.870090609 · Cited by 68
The Striatum Is the Most Vulnerable Region in the Brain to Mitochondrial Energy Compromise: A Hypothesis to Explain Its Specific Vulnerability
Nishino, H., Hida, H., Kumazaki, M., Shimano, Y., Nakajima, K., SHIMIZU, H., OOIWA, T., & Baba, H. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.251 · Cited by 67
Risk factors for the onset and progression of Huntington disease
Chao, T.-K., Hu, J. Y., & Pringsheim, T. M. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.01.005 · Cited by 66
Molecular analysis of late onset Huntington's disease.
Kremer, B. P. H., Squitieri, F., Telenius, H., Andrew, S. E., Theilmann, J., Spence, N., Goldberg, Y. P., & Hayden, M. R. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.991 · Cited by 66
Homozygous inheritance of the Machado‐Joseph disease gene
Lang, A. E., Rogaeva, E. A., Tsuda, T., Hutterer, J., & George‐Hyslop, P. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360318 · Cited by 66
Effect of CAG repeat length on psychiatric disorders in Huntington’s disease
Vassos, E., Πάνας, Μ., Kladi, A., & Vassilopoulos, D. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.008 · Cited by 66
Codon repeats in genes associated with human diseases: fewer repeats in the genes of nonhuman primates and nucleotide substitutions concentrated at the sites of reiteration.
Djian, P., Hancock, J. M., & Chana, H. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.417 · Cited by 65
Caenorhabditis elegans as a model system for studying aging-associated neurodegenerative diseases
Pelt, K. M. V., & Truttmann, M. C. (2020) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.05.001 · Cited by 62
What is the Pathogenic CAG Expansion Length in Huntington’s Disease?
Donaldson, J., Powell, S., Rickards, N., Holmans, P., & Jones, L. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-200445 · Cited by 64
Error Processing in Huntington's Disease
Beste, C., Carsten Saft, C., Andrich, J., Gold, R., & Falkenstein, M. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000086 · Cited by 65
Initial results of a genome survey for novel alzheimer's disease risk genes: Association with a locus on the X chromosome
Zubenko, G. S., Stiffler, J. S., Hughes, H. B., Hurtt, M. R., & Kaplan, B. B. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980328)81:2 · Cited by 18
Widespread remodeling of proteome solubility in response to different protein homeostasis stresses
Sui, X., Pires, D. E. V., Ormsby, A. R., Cox, D., Nie, S., Vecchi, G., Vendruscolo, M., Ascher, D. B., Reid, G. E., & Hatters, D. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912897117 · Cited by 62
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
Aldous, S. G., Smith, E. J., Landles, C., Osborne, G. F., Cañibano-Pico, M., Nita, I. M., Phillips, J. M., Zhang, Y., Jin, B., Hirst, M. B., et al. (2024) · Brain · doi:10.1093/brain/awae063 · Cited by 63
Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds
Gayán, J., Brocklebank, D., Andresen, J. M., Alkorta‐Aranburu, G., Cader, M. Z., Roberts, S. A., Cherny, S. S., Wexler, N. S., Cardon, L. R., & Housman, D. E. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20317 · Cited by 63
Self-citation
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin
Tanaka, Y., Igarashi, S., Nakamura, M., Gafni, J., Torcassi, C., Schilling, G., Crippen, D., Wood, J., Sawa, A., Jenkins, N. A., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.014 · Cited by 63
Self-citation
H untington's D isease ( HD ): Degeneration of Select Nuclei, Widespread Occurrence of Neuronal Nuclear and Axonal Inclusions in the Brainstem
Rüb, U., Hentschel, M., Stratmann, K., Brunt, E. R. P., Heinsen, H., Seidel, K., Bouzrou, M., Auburger, G. W. J., Paulson, H. L., Vonsattel, J., et al. (2013) · Brain Pathology · doi:10.1111/bpa.12115 · Cited by 63
Self-citation
Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin
Cyr, M., Sotnikova, T. D., Gainetdinov, R. R., & Caron, M. G. (2006) · The FASEB Journal · doi:10.1096/fj.06-6533fje · Cited by 64
The Ubiquitin-Proteasome System in Huntington’s Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
Schipper-Krom, S., Juenemann, K., & Reits, E. A. (2012) · Biochemistry Research International · doi:10.1155/2012/837015 · Cited by 64
Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and machado‐joseph disease
Lopes‐Cendes, Í., Maciel, P., Kish, S. J., Gaspar, C., Silveira, I., Robitaille, Y., Clark, H. B., Koeppen, A. H., NANCE, M. A., Schut, L. J., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400211 · Cited by 63
Huntington's disease: CAG genetics expands neurobiology
Gusella, J. F., & MacDonald, M. E. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80072-7 · Cited by 63
Self-citation
At Risk for Huntington Disease
The Huntington Study Group PHAROS Investigators* (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.991 · Cited by 62
Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology
Ross, C. A., Bêcher, M. W., Colomer, V., Engelender, S., Wood, J. D., & Sham, A. H. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00898.x · Cited by 63
Self-citation
DNA slip-outs cause RNA polymerase II arrest in vitro : potential implications for genetic instability
Salinas-Rios, V., Belotserkovskii, B. P., & Hanawalt, P. C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr429 · Cited by 64
The role of immunity in Huntington's disease
Soulet, D., & Cicchetti, F. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.28 · Cited by 62
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
Li, X., Chang, R., Liu, X., & Li, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s58470 · Cited by 62
Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes
Baine, F., Kay, C., Ketelaar, M. E., Collins, J. A., Semaka, A., Doty, C. N., Krause, A., Greenberg, L. S., & Hayden, M. R. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.2 · Cited by 62
Simple sequence repeats in zebra finch (Taeniopygia guttata) expressed sequence tags: a new resource for evolutionary genetic studies of passerines
Slate, J., Hale, M. C., & Birkhead, T. R. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-52 · Cited by 63
Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado‐Joseph disease
Onodera, O., Idezuka, J., Igarashi, S., Takiyama, Y., Endo, K., Takano, H., Oyake, M., Tanaka, H., Inuzuka, T., Hayashi, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430305 · Cited by 62
Role of SUMOylation in Neurodegenerative Diseases
Mandel, N., & Agarwal, N. (2022) · Cells · doi:10.3390/cells11213395 · Cited by 62
Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations
Kovtun, I. V., Thornhill, A. R., & McMurray, C. T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh325 · Cited by 61
The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington’s Disease
Dong, X., Tsuji, J., Labadorf, A. T., Roussos, P., Chen, J., Myers, R. H., Akbarian, S., & Weng, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144398 · Cited by 67
Self-citation
Epidemiology of Huntington disease
Kay, C., Hayden, M. R., & Leavitt, B. R. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801893-4.00003-1 · Cited by 61
Cognitive Manifestations of Huntington Disease in Relation to Genetic Structure and Clinical Onset
Jason, G. W., Suchowersky, O., Pajurkova, E. M., Graham, L. M., Klimek, M. L., Garber, A. T., & Poirier-Heine, D. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210019008 · Cited by 61
PET/CT in diagnosis of movement disorders
Berti, V., Pupi, A., & Mosconi, L. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06025.x · Cited by 60
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease
Arning, L., Haghikia, A., Taherzadeh-Fard, E., Carsten Saft, C., Andrich, J., Puła, B., Höxtermann, S., Wieczorek, S., Akkad, D. A., Perrech, M., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0589-2 · Cited by 60
Huntington’s Disease: Relationship Between Phenotype and Genotype
Sun, Y., Zhang, Y.-B., & Wu, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9662-8 · Cited by 60
Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets
Wang, J. K. T., Langfelder, P., Horvath, S., & Palazzolo, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00149 · Cited by 61
Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family
Uyama, E., Kondo, I., Uchino, M., Fukushima, T., Murayama, N., Kuwano, A., Inokuchi, N., Ohtani, Y., & Ando, M. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00019-x · Cited by 60
How do neurons die in neurodegenerative diseases?
Kanazawa, I. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02017-2 · Cited by 60
The Genetic Defect Causing Huntington’s Disease: Repeated in Other Contexts?
Gusella, J. F., Persichetti, F., & MacDonald, M. E. (1997) · Molecular Medicine · doi:10.1007/bf03401677 · Cited by 60
Self-citation
Dynamic mutations on the move.
Sutherland, G. R., & Richards, R. I. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.978 · Cited by 60
Juvenile Huntington disease in the Netherlands
Siesling, S., der Vlis, M. V.-V., & Roos, R. A. C. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00069-6 · Cited by 59
Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues
Roberts, J. S., & Uhlmann, W. R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.005 · Cited by 62
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease.
DeStefano, A. L., Cupples, L. A., Maciel, P., Gaspar, C., Radvany, J., Dawson, D. M., Sudarsky, L. R., Corwin, L., Coutinho, P., & MacLeod, P. (1996) · PubMed Central · Cited by 59
Genetic and environmental factors in the pathogenesis of Huntington’s disease
van Dellen, A., & Hannan, A. J. (2004) · Neurogenetics · doi:10.1007/s10048-003-0169-5 · Cited by 59
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype
Krause, A., Mitchell, C., Essop, F., Tager, S., Temlett, J. A., Stévanin, G., Ross, C. A., Rudnicki, D. D., & Margolis, R. L. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32332 · Cited by 58
Self-citation
A Compact β Model of huntingtin Toxicity
Zhang, Q. C., Yeh, T.-L., Leyva, J. A., Frank, L. G., Miller, J. M. L., Kim, Y., Langen, R., Finkbeiner, S. M., Amzel, L. M., Ross, C. A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192013 · Cited by 57
Self-citation
Differential pattern in tissue-specific somatic mosaicism of expanded CAG trinucleotide repeat in dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and X-linked recessive spinal and bulbar muscular atrophy
Tanaka, F., Sobue, G., Doyu, M., Ito, Y., Yamamoto, M., Shimada, N., Yamamoto, K., Riku, S., Hshizume, Y., & Mitsuma, T. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00249-2 · Cited by 58
Partial resistance to malonate‐induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length
Hansson, O., Castilho, R. F., Korhonen, L., Lindholm, D., Bates, G. P., & Brundin, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00482.x · Cited by 58
Hereditary Late-Onset Chorea Without Significant Dementia
Britton, J. W., Uitti, R. J., Ahlskog, J. E., Robinson, R. G., Kremer, B. P. H., & Hayden, M. R. (1995) · Neurology · doi:10.1212/wnl.45.3.443 · Cited by 57
The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients
Metzger, S., Walter, C., Rieß, O., Roos, R. A. C., Nielsen, J. E., Craufurd, D., REGISTRY Investigators of the European Huntington’s Disease Network, & Nguyen, H. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068951 · Cited by 55
Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27–35 CAG)
Hendricks, A. E., Latourelle, J. C., Lunetta, K. L., Cupples, L. A., Wheeler, V. C., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32901 · Cited by 56
Self-citation
Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival
Burrus, C. J., McKinstry, S. U., Kim, N., Ozlu, M. I., Santoki, A., Fang, F. Y., Ma, A., Karadeniz, Y. B., Worthington, A. K., Dragatsis, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.069 · Cited by 57
hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
Cervo, P. R. D. V., Besusso, D., Conforti, P., & Cattaneo, E. F. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00465-0 · Cited by 58
Dentatorubral-pallidoluysian atrophy (DRPLA): Close correlation of CAG repeat expansions with the wide spectrum of clinical presentations and prominent anticipation
Ikeuchi, T., Onodera, O., Oyake, M., Koide, R., Tanaka, H., & Tsuji, S. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90013-6 · Cited by 55
Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome
Ripaud, L., Chumakova, V., Antonin, M., Hastie, A. R., Pinkert, S., Körner, R., Ruff, K. M., Pappu, R. V., Hornburg, D., Mann, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421313111 · Cited by 54
Allele‐Selective Inhibition of Mutant Huntingtin by Peptide Nucleic Acid‐Peptide Conjugates, Locked Nucleic Acid, and Small Interfering RNA
Hu, J., Matsui, M., & Corey, D. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04975.x · Cited by 55
Molecular Imaging Markers to Track Huntington’s Disease Pathology
Wilson, H., Micco, R. D., Niccolini, F., & Politis, M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00011 · Cited by 55
Male-to-male transmission in extended pedigrees with multiple cases of autism
Hallmayer, J. F., Spiker, D., Lotspeich, L. J., McMahon, W. M., Petersen, P. B., Nicholas, P., Pingree, C., & Ciaranello, R. D. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960216)67:1 · Cited by 35
ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group.
(1998) · PubMed Central · Cited by 55
Huntington disease: new insights on the role of huntingtin cleavage
Wellington, C. L., Leavitt, B. R., & Hayden, M. R. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6284-2_1 · Cited by 55
Long-read single-molecule maps of the functional methylomePreprint
Sharim, H., Grunwald, A., Gabrieli, T., Michaeli, Y., Margalit, S., Torchinsky, D., Arielly, R., Nifker, G., Juhasz, M., Gularek, F., et al. (2019) · Genome Research · doi:10.1101/gr.240739.118 · Cited by 55
The role of genetics in the establishment and maintenance of the epigenome
Huidobro, C., Fernández, A. F., & Fraga, M. F. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1296-2 · Cited by 55
Exploratory Activity and Fear Conditioning Abnormalities Develop Early in R6/2 Huntington's Disease Transgenic Mice.
Bolivar, V. J., MANLEY, K. M., & Messer, A. C. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1233 · Cited by 54
Technical factors that influence neural transplant safety in Huntington's disease
Freeman, T. B., Cicchetti, F., Bachoud‐Lévi, A., & Dunnett, S. B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.031 · Cited by 54
Integrative hypothesis for Huntington’s disease: a brief review on experimental evidence.
de la Cruz, V. P., & Santamarı́a, A. (2007) · Physiological Research · doi:10.33549/physiolres.931049 · Cited by 54
Speech in prodromal and symptomatic Huntington’s disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases
Chan, J. C. S., Stout, J. C., & Vogel, A. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.009 · Cited by 54
Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan
Kameya, T., Abe, K., Aoki, M., Sahara, M., Tobita, M., Konno, H., & Itoyama, Y. (1995) · Neurology · doi:10.1212/wnl.45.8.1587 · Cited by 54
Identification of an HD patient with a (CAG) 180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage
Sathasivam, K., Amaechi, I., Mangiarini, L., & Bates, G. P. (1997) · Human Genetics · doi:10.1007/s004390050432 · Cited by 54
Roles for the 8-Oxoguanine DNA Repair System in Protecting Telomeres From Oxidative Stress
Rosa, M. D., Johnson, S. A., & Opresko, P. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.758402 · Cited by 58
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
Creus‐Muncunill, J., & Ehrlich, M. E. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00782-9 · Cited by 57
Huntington’s Disease
Roze, E. F., Bonnet, C., Bétuing, S., & Caboche, J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_5 · Cited by 54
Triplet repeats strike again
Miwa, S. (1994) · Nature Genetics · doi:10.1038/ng0194-3 · Cited by 53
Genetic anticipation and imprinting in bipolar I illness
Grigoroiu‐Serbânescu, M., Wickramaratne, P. J., Hodge, S. E., Milea, S., & Mihăilescu, R. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.2.162 · Cited by 53
Prion-Like Characteristics of Polyglutamine-Containing ProteinsPreprint
Pearce, M. M. P., & Kopito, R. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024257 · Cited by 53
Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease
Samadi, P., Boutet, A., Rymar, V. V., Rawal, K., Maheux, J., Kvann, J. C., Tomaszewski, M., Beaubien, F., Cloutier, J., Lévesque, D., et al. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00858.x · Cited by 52
Inherited CAG·CTG allele length is a major modifier of somatic mutation length variability in Huntington disease
Veitch, N., Ennis, M., McAbney, J. P., Shelbourne, P., & Monckton, D. G. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.01.002 · Cited by 52
Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage
Möncke‐Buchner, E. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf082 · Cited by 52
A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles
Lee, A. L., Ung, H. M., Sands, L. P., & Kikis, E. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173644 · Cited by 55
Early onset Huntington disease: a neuronal degeneration syndrome
Seneca, S., Fagnart, D., Keymolen, K., Lissens, W., Hasaerts, D., Debulpaep, S., Desprechins, B., Liebaers, I., & Meırleır, L. D. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1537-3 · Cited by 52
X‐Linked recessive bulbospinal neuronopathy: Clinical phenotypes and cag repeat size in androgen receptor gene
Shimada, N., Sobue, G., Doyu, M., Yamamoto, K., Yasuda, T., Mukai, E., Kachi, T., & Mitsuma, T. (1995) · Muscle & Nerve · doi:10.1002/mus.880181206 · Cited by 52
Two neuronal cell lines expressing the myelin basic protein gene display differences in their in vitro survival and in their response to glia
Bongarzone, E. R., Foster, L. M., Byravan, S., Casaccia‐Bonnefil, P., Schonmann, V., & Campagnoni, A. T. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981101)54:3 · Cited by 21
Autophagy preferentially degrades non-fibrillar polyQ aggregates
(2024) · doi:10.1016/j.molcel.2024.04.018 · Cited by 51
New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation
Waldvogel, H. J., Kim, E. H., Thu, D. C. V., Tippett, L. J., & Faull, R. L. M. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-2012-120018 · Cited by 51
New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles
Maat‐Kievit, A., LOSEKOOT, M., BERG, H. V. D. B.-V. D., van Ommen, G. B., NIERMEIJER, M., Breuning, M. H., & Tibben, A. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.4.e12 · Cited by 51
Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene.
Gellera, C., Meoni, C., Castellotti, B., Zappacosta, B., Girotti, F., Taroni, F., & DiDonato, S. (1996) · PubMed Central · Cited by 51
Distinct Behavioral and Neuropathological Abnormalities in Transgenic Mouse Models of HD and DRPLA
Schilling, G., Jinnah, H. A., Gonzales, V., Coonfield, M. L., Kim, Y., Wood, J., Price, D. L., Li, X., Jenkins, N. A., Copeland, N. G., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0385 · Cited by 51
Self-citation
The use of quantitative oculometry in the assessment of Huntington’s disease
Ali, F. R., Michell, A. W., Barker, R., & Carpenter, R. H. S. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0143-6 · Cited by 52
Mutation analysis in patients with possible but apparently sporadic Huntington's disease
Davis, M. B., Bateman, D., Quinn, N. P., MARSDEN, C. D., & Harding, A. E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92208-x · Cited by 51
How do protein aggregates escape quality control in neurodegeneration?
Koopman, M. B., Ferrari, L., & Rüdiger, S. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.006 · Cited by 54
Huntington’s disease and striatal signaling
Roze, E. F. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00055 · Cited by 56
ASK1 and MAP2K6 as modifiers of age at onset in Huntington’s disease
Arning, L., Monté, D., Hansen, W., Wieczorek, S., Jagiello, P., Akkad, D. A., Andrich, J., Kraus, P. H., Carsten Saft, C., & Epplen, J. T. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0299-6 · Cited by 50
High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington’s disease CAG knock-in mice across multiple genetic backgrounds
Ament, S. A., Pearl, J. R., Grindeland, A., Claire, J. S., Earls, J. C., Kovalenko, M. V., Gillis, T., Mysore, J. S., Gusella, J. F., Lee, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx006 · Cited by 50
Self-citation
Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease
Valionyte, E., Yang, Y., Roberts, S. L., Kelly, J., Lu, B., & Luo, S. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.11.012 · Cited by 51
Recent advances in Huntingtonʼs disease: implications for experimental therapeutics
Feigin, A., & Zgaljardic, D. J. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200208000-00013 · Cited by 50
Aberrant liquid-liquid phase separation and amyloid aggregation of proteins related to neurodegenerative diseases
Ahmad, A., Uversky, V. N., & Khan, R. H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.08.132 · Cited by 53
Huntington’s disease: nearly four decades of human molecular genetics
Gusella, J. F., Lee, J., & MacDonald, M. E. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab170 · Cited by 50
Self-citation
Emerging roles for high‐density lipoproteins in neurodegenerative disorders
Bahrami, A., Barreto, G. E., Lombardi, G., Pirro, M., & Sahebkar, A. (2019) · BioFactors · doi:10.1002/biof.1541 · Cited by 50
Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis
Glajch, K. E., & Sadri‐Vakili, G. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-140134 · Cited by 47

Authors: Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., Gusella, J., & MacDonald, M.
Affiliations: Massachusetts General Hospital (US)
Boston University (US)
University of Rome Tor Vergata (IT)
Johns Hopkins University (US)
Indiana University (US)
University of Rochester Medicine (US)
Rutgers, The State University of New Jersey (US)
Emory University (US)
Harvard University (US)
Universidad del Zulia (VE)
Long Island Jewish Medical Center (US)
Kennedy Krieger Institute (US)
Hospital Virgen del Camino (ES)
University of Mississippi Medical Center (US)
Hereditary Disease Foundation (US)
ORCID: Myers, R.
Novelletto, A.
Persichetti, F.
Frontali, M.
Ross, C.
Shoulson, I.
Koroshetz, W.
Bonilla, E.
Dure, L.
Snodgrass, S.
Wexler, N.
Gusella, J.
Venue: Nature Genetics
Publisher: Springer Science and Business Media LLC
Published: 1993-08
Volume: 4
Issue: 4
Pages: 387-392
ISSN: 1061-4036 (ISSN-L)
1546-1718
DOI: 10.1038/ng0893-387
OpenAlex: W1994285647
Cited by: 1,089
References: 35
Citations by year: 2026: 17 · 2025: 27 · 2024: 37 · 2023: 23 · 2022: 39 · 2021: 42 · 2020: 36 · 2019: 38 · 2018: 35 · 2017: 42 · 2016: 26 · 2015: 35 · 2014: 31 · 2013: 39 · 2012: 47
FWCI: 17.83
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns017978-06)
National Institute of Neurological Disorders and Stroke (NS17978, NS16375, NS 16367)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, trinucleotide repeat expansion, repeat instability, age of onset, paternal transmission, spermatogenesis, presymptomatic diagnosis, repeat length
MeSH terms: Adult, Age Factors, Female, Genetic Carrier Screening, Humans, Huntington Disease, Genetic Linkage, Male, Middle Aged, Pedigree, Repetitive Sequences, Nucleic Acid, Spermatozoa, Linkage Disequilibrium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Trinucleotide repeat length instability and age of onset in Huntington's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks